Close

AVI BioPharma, Inc. (AVII) Misses Q1 EPS by 6c

May 10, 2012 4:43 PM EDT
AVI BioPharma, Inc. (NASDAQ: AVII) reported Q1 EPS of ($0.13), $0.06 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $11.2 million versus the consensus estimate of $11.05 million.

For earnings history and earnings-related data on AVI BioPharma, Inc. (AVII) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings